Sai Life Sciences has launched Unit VI, a new facility in Bidar, India, dedicated to the production of Veterinary Active Pharmaceutical Ingredients (APIs). 

This expansion, located alongside the company's flagship API manufacturing site, Unit IV, aims to meet the growing global demand for high-quality veterinary medicines. 

The facility is designed to meet strict regulatory and sustainability standards and will provide scalable manufacturing solutions to leading global animal health companies. 

This move positions Sai Life Sciences to capture opportunities in the niche and high-value segment of the veterinary pharmaceutical market.